UniProt ID | ARP3_HUMAN | |
---|---|---|
UniProt AC | P61158 | |
Protein Name | Actin-related protein 3 | |
Gene Name | ACTR3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 418 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell projection . In pre-apoptotic cells, colocalizes with MEFV in large specks (pyroptosomes) (PubMed:19109554). | |
Protein Description | Functions as ATP-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the pointed end of the daughter actin filament. Plays a role in ciliogenesis.. | |
Protein Sequence | MAGRLPACVVDCGTGYTKLGYAGNTEPQFIIPSCIAIKESAKVGDQAQRRVMKGVDDLDFFIGDEAIEKPTYATKWPIRHGIVEDWDLMERFMEQVIFKYLRAEPEDHYFLLTEPPLNTPENREYTAEIMFESFNVPGLYIAVQAVLALAASWTSRQVGERTLTGTVIDSGDGVTHVIPVAEGYVIGSCIKHIPIAGRDITYFIQQLLRDREVGIPPEQSLETAKAVKERYSYVCPDLVKEFNKYDTDGSKWIKQYTGINAISKKEFSIDVGYERFLGPEIFFHPEFANPDFTQPISEVVDEVIQNCPIDVRRPLYKNIVLSGGSTMFRDFGRRLQRDLKRTVDARLKLSEELSGGRLKPKPIDVQVITHHMQRYAVWFGGSMLASTPEFYQVCHTKKDYEEIGPSICRHNPVFGVMS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGRLPACV ------CCCCCCEEE | 16.29 | 19413330 | |
8 | S-nitrosylation | MAGRLPACVVDCGTG CCCCCCEEEEECCCC | 2.64 | 2212679 | |
8 | S-palmitoylation | MAGRLPACVVDCGTG CCCCCCEEEEECCCC | 2.64 | 26865113 | |
12 | S-nitrosylation | LPACVVDCGTGYTKL CCEEEEECCCCCEEC | 3.38 | 2212679 | |
12 | S-palmitoylation | LPACVVDCGTGYTKL CCEEEEECCCCCEEC | 3.38 | 26865113 | |
14 | Phosphorylation | ACVVDCGTGYTKLGY EEEEECCCCCEECCC | 33.09 | 28442448 | |
16 | Nitration | VVDCGTGYTKLGYAG EEECCCCCEECCCCC | 10.67 | - | |
16 | Phosphorylation | VVDCGTGYTKLGYAG EEECCCCCEECCCCC | 10.67 | 27155012 | |
17 | Phosphorylation | VDCGTGYTKLGYAGN EECCCCCEECCCCCC | 22.57 | 28152594 | |
18 | Ubiquitination | DCGTGYTKLGYAGNT ECCCCCEECCCCCCC | 31.28 | - | |
25 | Phosphorylation | KLGYAGNTEPQFIIP ECCCCCCCCCCEECC | 48.39 | 28348404 | |
38 | Acetylation | IPSCIAIKESAKVGD CCCCEEEHHHHCCCH | 36.27 | 25953088 | |
38 | Ubiquitination | IPSCIAIKESAKVGD CCCCEEEHHHHCCCH | 36.27 | - | |
42 | Acetylation | IAIKESAKVGDQAQR EEEHHHHCCCHHHHH | 56.90 | 25953088 | |
42 | Ubiquitination | IAIKESAKVGDQAQR EEEHHHHCCCHHHHH | 56.90 | 21906983 | |
53 | Acetylation | QAQRRVMKGVDDLDF HHHHHHHCCCCCCCE | 53.58 | 23954790 | |
53 | Ubiquitination | QAQRRVMKGVDDLDF HHHHHHHCCCCCCCE | 53.58 | 21906983 | |
53 | Ubiquitination | QAQRRVMKGVDDLDF HHHHHHHCCCCCCCE | 53.58 | 21890473 | |
69 | Acetylation | IGDEAIEKPTYATKW CCHHHCCCCCCCCCC | 36.22 | 26051181 | |
69 | Ubiquitination | IGDEAIEKPTYATKW CCHHHCCCCCCCCCC | 36.22 | 21906983 | |
69 | Ubiquitination | IGDEAIEKPTYATKW CCHHHCCCCCCCCCC | 36.22 | 21890473 | |
75 | Ubiquitination | EKPTYATKWPIRHGI CCCCCCCCCCCCCCC | 42.68 | 21906983 | |
89 | Sulfoxidation | IVEDWDLMERFMEQV CCCCHHHHHHHHHHH | 3.01 | 30846556 | |
99 | Ubiquitination | FMEQVIFKYLRAEPE HHHHHHHHHHHCCCC | 32.05 | 21906983 | |
99 | Ubiquitination | FMEQVIFKYLRAEPE HHHHHHHHHHHCCCC | 32.05 | 21890473 | |
100 | Phosphorylation | MEQVIFKYLRAEPED HHHHHHHHHHCCCCC | 7.23 | 22817900 | |
109 | Phosphorylation | RAEPEDHYFLLTEPP HCCCCCCEEECCCCC | 14.29 | 17360941 | |
113 | Phosphorylation | EDHYFLLTEPPLNTP CCCEEECCCCCCCCC | 48.90 | 29255136 | |
119 | Phosphorylation | LTEPPLNTPENREYT CCCCCCCCCCCCCEE | 39.40 | 29255136 | |
133 | Phosphorylation | TAEIMFESFNVPGLY EEEEEEHHCCCCHHH | 15.74 | - | |
140 | Phosphorylation | SFNVPGLYIAVQAVL HCCCCHHHHHHHHHH | 7.86 | - | |
152 | Phosphorylation | AVLALAASWTSRQVG HHHHHHHHHHCCCCC | 25.86 | - | |
184 | Phosphorylation | VIPVAEGYVIGSCIK EEEECCCEEEHHHHH | 4.76 | 20090780 | |
188 | Phosphorylation | AEGYVIGSCIKHIPI CCCEEEHHHHHCCCC | 11.09 | - | |
189 | S-palmitoylation | EGYVIGSCIKHIPIA CCEEEHHHHHCCCCC | 3.97 | 29575903 | |
191 | Acetylation | YVIGSCIKHIPIAGR EEEHHHHHCCCCCCC | 39.55 | 26051181 | |
191 | Ubiquitination | YVIGSCIKHIPIAGR EEEHHHHHCCCCCCC | 39.55 | - | |
201 | Phosphorylation | PIAGRDITYFIQQLL CCCCCHHHHHHHHHH | 19.37 | 28450419 | |
202 | Phosphorylation | IAGRDITYFIQQLLR CCCCHHHHHHHHHHH | 10.06 | 22115753 | |
225 | Acetylation | EQSLETAKAVKERYS HHHHHHHHHHHHHHH | 62.22 | 25953088 | |
225 | Ubiquitination | EQSLETAKAVKERYS HHHHHHHHHHHHHHH | 62.22 | 21906983 | |
228 | Ubiquitination | LETAKAVKERYSYVC HHHHHHHHHHHHCCC | 41.14 | - | |
231 | Phosphorylation | AKAVKERYSYVCPDL HHHHHHHHHCCCHHH | 12.87 | 21082442 | |
232 | Phosphorylation | KAVKERYSYVCPDLV HHHHHHHHCCCHHHH | 19.81 | 28152594 | |
233 | Phosphorylation | AVKERYSYVCPDLVK HHHHHHHCCCHHHHH | 9.35 | 28152594 | |
240 | 2-Hydroxyisobutyrylation | YVCPDLVKEFNKYDT CCCHHHHHHHHHCCC | 64.98 | - | |
240 | Acetylation | YVCPDLVKEFNKYDT CCCHHHHHHHHHCCC | 64.98 | 19608861 | |
240 | Malonylation | YVCPDLVKEFNKYDT CCCHHHHHHHHHCCC | 64.98 | 26320211 | |
240 | Ubiquitination | YVCPDLVKEFNKYDT CCCHHHHHHHHHCCC | 64.98 | 21890473 | |
240 | Ubiquitination | YVCPDLVKEFNKYDT CCCHHHHHHHHHCCC | 64.98 | 21890473 | |
244 | 2-Hydroxyisobutyrylation | DLVKEFNKYDTDGSK HHHHHHHHCCCCCHH | 50.23 | - | |
244 | Acetylation | DLVKEFNKYDTDGSK HHHHHHHHCCCCCHH | 50.23 | 19608861 | |
244 | Malonylation | DLVKEFNKYDTDGSK HHHHHHHHCCCCCHH | 50.23 | 26320211 | |
244 | Ubiquitination | DLVKEFNKYDTDGSK HHHHHHHHCCCCCHH | 50.23 | 19608861 | |
251 | Acetylation | KYDTDGSKWIKQYTG HCCCCCHHHHHHHHC | 59.47 | 19608861 | |
251 | Malonylation | KYDTDGSKWIKQYTG HCCCCCHHHHHHHHC | 59.47 | 26320211 | |
251 | Ubiquitination | KYDTDGSKWIKQYTG HCCCCCHHHHHHHHC | 59.47 | 21890473 | |
251 | Ubiquitination | KYDTDGSKWIKQYTG HCCCCCHHHHHHHHC | 59.47 | 21890473 | |
254 | 2-Hydroxyisobutyrylation | TDGSKWIKQYTGINA CCCHHHHHHHHCCCC | 35.82 | - | |
254 | Acetylation | TDGSKWIKQYTGINA CCCHHHHHHHHCCCC | 35.82 | 19608861 | |
254 | Malonylation | TDGSKWIKQYTGINA CCCHHHHHHHHCCCC | 35.82 | 26320211 | |
254 | Ubiquitination | TDGSKWIKQYTGINA CCCHHHHHHHHCCCC | 35.82 | 21890473 | |
254 | Ubiquitination | TDGSKWIKQYTGINA CCCHHHHHHHHCCCC | 35.82 | 21890473 | |
256 | Phosphorylation | GSKWIKQYTGINAIS CHHHHHHHHCCCCCC | 11.26 | 28152594 | |
257 | Phosphorylation | SKWIKQYTGINAISK HHHHHHHHCCCCCCC | 29.14 | 28152594 | |
264 | Sumoylation | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | - | |
264 | 2-Hydroxyisobutyrylation | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | - | |
264 | Acetylation | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | 25953088 | |
264 | Succinylation | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | 23954790 | |
264 | Sumoylation | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | - | |
264 | Ubiquitination | TGINAISKKEFSIDV HCCCCCCCCEEEEEC | 50.65 | - | |
265 | Ubiquitination | GINAISKKEFSIDVG CCCCCCCCEEEEECC | 58.14 | 21906983 | |
265 | Ubiquitination | GINAISKKEFSIDVG CCCCCCCCEEEEECC | 58.14 | 21890473 | |
268 | Phosphorylation | AISKKEFSIDVGYER CCCCCEEEEECCCHH | 20.97 | 24719451 | |
273 | Phosphorylation | EFSIDVGYERFLGPE EEEEECCCHHHCCCE | 12.09 | 28152594 | |
317 | Acetylation | DVRRPLYKNIVLSGG CCCCCCCCCEEECCC | 48.13 | 25953088 | |
317 | Ubiquitination | DVRRPLYKNIVLSGG CCCCCCCCCEEECCC | 48.13 | - | |
322 | Phosphorylation | LYKNIVLSGGSTMFR CCCCEEECCCCHHHH | 30.16 | 30108239 | |
325 | Phosphorylation | NIVLSGGSTMFRDFG CEEECCCCHHHHHHH | 21.89 | 30108239 | |
326 | Phosphorylation | IVLSGGSTMFRDFGR EEECCCCHHHHHHHH | 24.49 | 30108239 | |
327 | Sulfoxidation | VLSGGSTMFRDFGRR EECCCCHHHHHHHHH | 2.51 | 30846556 | |
348 | 2-Hydroxyisobutyrylation | RTVDARLKLSEELSG HHHHHHHHCCHHHCC | 44.40 | - | |
348 | Acetylation | RTVDARLKLSEELSG HHHHHHHHCCHHHCC | 44.40 | 25953088 | |
348 | Malonylation | RTVDARLKLSEELSG HHHHHHHHCCHHHCC | 44.40 | 26320211 | |
348 | Ubiquitination | RTVDARLKLSEELSG HHHHHHHHCCHHHCC | 44.40 | 21906983 | |
350 | Phosphorylation | VDARLKLSEELSGGR HHHHHHCCHHHCCCC | 27.69 | 23911959 | |
354 | Phosphorylation | LKLSEELSGGRLKPK HHCCHHHCCCCCCCC | 42.34 | 27251275 | |
359 | Ubiquitination | ELSGGRLKPKPIDVQ HHCCCCCCCCCCCHH | 50.03 | 21906983 | |
359 | Ubiquitination | ELSGGRLKPKPIDVQ HHCCCCCCCCCCCHH | 50.03 | 21890473 | |
361 | Ubiquitination | SGGRLKPKPIDVQVI CCCCCCCCCCCHHHH | 53.68 | 21906983 | |
361 | Ubiquitination | SGGRLKPKPIDVQVI CCCCCCCCCCCHHHH | 53.68 | 21890473 | |
375 | Phosphorylation | ITHHMQRYAVWFGGS HCCCHHHHHHHHCCC | 6.66 | 20068231 | |
383 | Sulfoxidation | AVWFGGSMLASTPEF HHHHCCCHHCCCHHH | 4.02 | 30846556 | |
387 | Phosphorylation | GGSMLASTPEFYQVC CCCHHCCCHHHHHHH | 22.64 | 20068231 | |
391 | Phosphorylation | LASTPEFYQVCHTKK HCCCHHHHHHHCCCC | 9.81 | 20068231 | |
396 | Phosphorylation | EFYQVCHTKKDYEEI HHHHHHCCCCCHHHH | 34.36 | 20068231 | |
398 | 2-Hydroxyisobutyrylation | YQVCHTKKDYEEIGP HHHHCCCCCHHHHCH | 67.70 | - | |
398 | Acetylation | YQVCHTKKDYEEIGP HHHHCCCCCHHHHCH | 67.70 | 26051181 | |
398 | Malonylation | YQVCHTKKDYEEIGP HHHHCCCCCHHHHCH | 67.70 | 26320211 | |
398 | Succinylation | YQVCHTKKDYEEIGP HHHHCCCCCHHHHCH | 67.70 | 23954790 | |
398 | Ubiquitination | YQVCHTKKDYEEIGP HHHHCCCCCHHHHCH | 67.70 | - | |
400 | Phosphorylation | VCHTKKDYEEIGPSI HHCCCCCHHHHCHHH | 25.09 | 28152594 | |
406 | Phosphorylation | DYEEIGPSICRHNPV CHHHHCHHHHCCCCC | 29.16 | 20068231 | |
408 | Glutathionylation | EEIGPSICRHNPVFG HHHCHHHHCCCCCCC | 4.20 | 22555962 | |
417 | Sulfoxidation | HNPVFGVMS------ CCCCCCCCC------ | 3.94 | 28183972 | |
418 | Phosphorylation | NPVFGVMS------- CCCCCCCC------- | 34.36 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARP3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARP3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARP3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-240; LYS-244; LYS-251 ANDLYS-254, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-16; TYR-202 AND TYR-231,AND MASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-231, AND MASSSPECTROMETRY. |